Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Jiangsu Hansoh Pharmaceutical Co., Ltd.)"
Count: 65
Selected: 0
NCT IDTitle
NCT05378178A PhaseⅠStudy of HS-10381 in Patients With Advanced Solid Tumors
NCT05367778Phase 1/2 Study of HS-10370 in Patients With Advanced Solid Tumors
NCT05367765A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
NCT05367700A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.
NCT05353205A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
NCT05207787Phase 1 Study of the HS-10365 in Patients With Advanced Solid Tumors
NCT05196971A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression
NCT05195203A Study of HS-10353 in Chinese Participants.
NCT05116410A Study of HS-20094 in Healthy Participants
NCT05044988A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer
NCT04986436Phase I Study to Evaluate Safety, Tolerability, and Pharmacokinetics of HS-10360 in Healthy Subjects.
NCT04951648A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation
NCT04951635A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer
NCT04923906Aumolertinib With or Without Chemotherapy as 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Sensitizing EGFR Mutations
NCT04881006Bioequivalence of Dapagliflozin 10 mg Tablets Under Fed Conditions
NCT04880993Bioequivalence of Dapagliflozin 10 mg Tablets Under Fasting Conditions
NCT04804267Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation
NCT04687241Almonertinib Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB Non-Small Cell Lung Cancer With EGFR-sensitive Mutations
NCT04652297Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers
NCT04631835Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
NCT04494373Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults
NCT04477096Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine
NCT04477057PhaseⅠStudy of the HS-10241 in Patients With Advanced Solid Tumors
NCT04060511A Phase 1 Study of HS-10342 In Patients With Advanced Solid Tumor
NCT03903809Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With NDD-CKD
NCT03903796Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection
NCT03902691Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis
NCT03849768A Study to Evaluate Safety and Efficacy of HS-10296 as First-Line Treatment in Patients
NCT03391440A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease
NCT03380793A Trial to Assess the Efficacy and Safety of Morinidazole in Patients With Appendicitis
NCT03243643Tolerability, Safety, Pharmacokinetics and Efficacy of HS-10241 Single Agent or Combined With Apatinib in Patients With Advanced Solid Tumors
NCT02981108A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC
NCT02977364A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours
NCT02750007Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients
NCT02746315Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple s.c Doses HS-20004 in Healthy Chinese Volunteers
NCT02746302Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers
NCT02619097Safety & Pharmacokinetics of Pegolsihematide for Treatment of Anemia Patient With Myelodysplastic Syndromes
NCT02586402Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis
NCT02511340A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients
NCT02477969Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
NCT02477865Efficacy and Safety Study of PEX168 in Monotherapy Diabetes Mellitus Type 2 Patients
NCT02472236Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects
NCT02467790Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function
NCT02461914Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects
NCT02447601Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects
NCT02403362Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis
NCT02366325Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis
NCT02366247Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B
NCT02366208Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B
NCT02314884Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid Tumours